COMMERCIALIZATION AGREEMENT BETWEENProduct Development and Commercialization Agreement • August 6th, 2013 • Exelixis, Inc. • Services-commercial physical & biological research • New York
Contract Type FiledAugust 6th, 2013 Company Industry JurisdictionTHIS PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT is made as of the 28th day of October, 2002 (the “Effective Date”) by and between Exelixis, Inc., a Delaware corporation (“EXEL”), and SmithKline Beecham Corporation, a Pennsylvania corporation, doing business as GlaxoSmithKline (“GSK”). EXEL and GSK are each referred to herein by name or as a “Party” or, collectively, as the “Parties.”